44 results
8-K
EX-10.3
AXLA
Axcella Health Inc.
17 Feb 23
Departure of Directors or Certain Officers
5:17pm
8-K
EX-10.1
AXLA
Axcella Health Inc.
17 Feb 23
Departure of Directors or Certain Officers
5:17pm
8-K
EX-10.2
AXLA
Axcella Health Inc.
17 Feb 23
Departure of Directors or Certain Officers
5:17pm
10-Q
2022 Q3
EX-10.2
AXLA
Axcella Health Inc.
Quarterly report
1 Nov 22
4:13pm
8-K
EX-10.1
AXLA
Axcella Health Inc.
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
8-K
EX-10.2
b7tb4 jxkx6dfsfih6k
23 Sep 22
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
7g1rudu68v4o7sfnn
23 Sep 22
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
54x0j z1kdrcwoupwe5
16 Mar 22
Axcella Therapeutics Announces $25 Million Registered Direct Offering of Common Stock Priced At the Market
8:30am
8-K
EX-10.1
zn2j53od8 97ivz0
7 Feb 22
Axcella Therapeutics Announces Appointment of New Chief Financial Officer
4:00pm
8-K
EX-10.1
fgtznwd6wwj
7 Dec 21
Departure of Directors or Certain Officers
6:15am
8-K
EX-10.1
l57 lrnf0
7 Sep 21
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-10.1
yj57rwk
3 Mar 21
Axcella Announces Alison D. Schecter, M.D., as President of R&D
5:26pm
8-K
EX-10.1
zsqy 972l
31 Aug 20
Entry into a Material Definitive Agreement
9:00am